See more : Wiscom Co.,Ltd. (024070.KS) Income Statement Analysis – Financial Results
Complete financial analysis of BIO-key International, Inc. (BKYI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BIO-key International, Inc., a leading company in the Security & Protection Services industry within the Industrials sector.
- Guolian Securities Co., Ltd. (601456.SS) Income Statement Analysis – Financial Results
- Vesuvius plc (VSVS.L) Income Statement Analysis – Financial Results
- Adrad Holdings Limited (AHL.AX) Income Statement Analysis – Financial Results
- Suzuki Motor Corporation (SZKMF) Income Statement Analysis – Financial Results
- China Strategic Holdings Limited (0235.HK) Income Statement Analysis – Financial Results
BIO-key International, Inc. (BKYI)
About BIO-key International, Inc.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.75M | 7.02M | 5.11M | 2.84M | 2.27M | 4.04M | 6.30M | 2.98M | 5.26M | 4.01M | 1.99M | 3.84M | 3.51M | 3.52M | 2.36M | 12.88M | 9.99M | 15.19M | 14.23M | 5.56M | 524.10K | 155.40K | 0.00 | 1.00 | 157.97K | 384.58K | 464.17K | 32.00K |
Cost of Revenue | 6.32M | 2.04M | 1.67M | 794.83K | 2.46M | 4.16M | 6.48M | 729.68K | 1.28M | 748.75K | 387.03K | 571.73K | 810.46K | 559.14K | 504.24K | 1.74M | 1.78M | 3.40M | 3.84M | 2.06M | 89.08K | 2.72K | 0.00 | -137.30K | -33.19K | 1.05M | 390.24K | 14.88K |
Gross Profit | 1.43M | 4.98M | 3.44M | 2.04M | -193.72K | -119.65K | -181.32K | 2.25M | 3.98M | 3.26M | 1.60M | 3.26M | 2.70M | 2.96M | 1.85M | 11.14M | 8.20M | 11.80M | 10.38M | 3.49M | 435.02K | 152.68K | 0.00 | 137.30K | 191.16K | -669.97K | 73.93K | 17.13K |
Gross Profit Ratio | 18.46% | 70.95% | 67.29% | 71.98% | -8.54% | -2.96% | -2.88% | 75.48% | 75.68% | 81.31% | 80.51% | 85.10% | 76.90% | 84.12% | 78.61% | 86.52% | 82.13% | 77.64% | 72.98% | 62.86% | 83.00% | 98.25% | 0.00% | 13,730,400.00% | 121.01% | -174.21% | 15.93% | 53.52% |
Research & Development | 2.39M | 3.25M | 2.36M | 1.40M | 1.33M | 1.42M | 1.66M | 2.01M | 1.56M | 1.63M | 1.34M | 947.37K | 1.12M | 1.06M | 927.24K | 4.49M | 4.99M | 6.51M | 6.85M | 2.98M | 1.04M | 1.08M | 947.93K | 1.14M | 856.69K | 1.57M | 563.05K | 386.61K |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.33M | 0.00 | 0.00 | 1.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 7.86M | 9.64M | 6.03M | 5.85M | 5.04M | 5.33M | 5.68M | 4.44M | 4.12M | 3.67M | 2.78M | 2.29M | 3.04M | 3.11M | 3.38M | 6.55M | 8.57M | 10.31M | 11.82M | 7.10M | 2.12M | 1.93M | 1.32M | 1.85M | 2.15M | 3.31M | 2.30M | 422.68K |
Other Expenses | 0.00 | 452.82K | 60.00K | -340.82K | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 137.30K | 485.79K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 10.26M | 13.35M | 8.44M | 6.90M | 6.37M | 6.75M | 7.34M | 6.45M | 5.68M | 5.30M | 4.12M | 3.24M | 4.15M | 4.16M | 4.31M | 11.04M | 13.57M | 16.83M | 18.67M | 10.08M | 3.16M | 3.01M | 2.27M | 3.13M | 3.49M | 4.88M | 2.86M | 809.29K |
Cost & Expenses | 16.58M | 15.39M | 10.12M | 7.70M | 8.83M | 10.91M | 13.82M | 7.18M | 6.96M | 6.04M | 4.51M | 3.81M | 4.96M | 4.72M | 4.81M | 12.78M | 15.35M | 20.22M | 22.51M | 12.14M | 3.24M | 3.01M | 2.27M | 2.99M | 3.46M | 5.94M | 3.25M | 824.17K |
Interest Income | 11.53K | 233.00 | 4.08K | 30.65K | 154.00 | 80.00 | 27.00 | 30.00 | 14.00 | 7.00 | 7.00 | 7.00 | 95.03K | 241.42K | 165.71K | 1.34K | 3.10K | 0.00 | 35.96K | 66.82K | 4.15K | 0.00 | 0.00 | 0.00 | 0.00 | 99.88K | 0.00 | 4.29K |
Interest Expense | 218.27K | 29.95K | 18.00K | 4.34M | 1.07M | 80.00 | 27.00 | 30.00 | 161.06K | 7.00 | 136.48K | 24.63K | 411.53K | 711.35K | 89.80K | 92.52K | 832.46K | 5.73M | 6.55M | 667.01K | 1.11M | 1.16M | 317.63K | 141.34K | 0.00 | 496.48K | 0.00 | 35.61K |
Depreciation & Amortization | 590.14K | 546.01K | 514.07K | 426.91K | 1.14M | 1.74M | 1.58M | 62.64K | 56.60K | 68.80K | 49.58K | 39.87K | 42.73K | 32.82K | 50.77K | 854.24K | 1.46M | 4.14M | 5.88M | 637.12K | 6.39K | -1.12K | 31.94K | 137.30K | 485.79K | 633.26K | 103.62K | 20.39K |
EBITDA | -7.85M | -11.37M | -4.53M | -4.90M | -12.38M | -5.13M | -2.70M | -4.14M | -1.61M | -1.83M | -2.39M | 67.77K | -1.32M | 94.40K | -2.61M | 1.13M | -3.91M | -887.95K | -4.44M | -4.55M | -2.71M | -2.86M | -2.23M | -2.85M | -2.82M | -4.92M | -2.68M | -700.00K |
EBITDA Ratio | -101.19% | -119.17% | -97.72% | -170.32% | -289.39% | -129.94% | -42.82% | -139.47% | -31.15% | -49.19% | -124.48% | 1.77% | -36.63% | -62.13% | -89.52% | 6.02% | -45.37% | -3.73% | -123.49% | -105.96% | -517.85% | -1,839.96% | 0.00% | -285,180,800.00% | -1,783.25% | -1,279.69% | -577.95% | -2,411.80% |
Operating Income | -8.83M | -9.69M | -5.00M | -4.86M | -6.56M | -6.87M | -4.28M | -4.20M | -1.70M | -2.04M | -2.52M | 27.89K | -1.45M | -1.20M | -2.46M | 98.19K | -5.36M | -5.03M | -8.29M | -6.58M | -2.72M | -2.86M | -2.27M | -2.99M | -3.30M | -5.55M | -2.79M | -792.17K |
Operating Income Ratio | -113.82% | -138.03% | -97.80% | -171.40% | -289.40% | -169.83% | -67.83% | -141.17% | -32.22% | -50.90% | -126.97% | 0.73% | -41.46% | -34.09% | -104.22% | 0.76% | -53.71% | -33.10% | -58.26% | -118.42% | -519.07% | -1,839.24% | 0.00% | -298,911,100.00% | -2,090.76% | -1,444.36% | -600.27% | -2,475.53% |
Total Other Income/Expenses | 170.47K | -2.01M | -123.93K | -4.47M | -1.07M | 80.00 | 27.00 | 12.12K | -160.13K | 157.26K | -57.67K | -24.62K | -416.49K | 550.23K | -206.08K | 86.34K | -204.35K | -6.05M | 4.61M | 1.81M | -1.11M | -1.16M | -317.63K | 0.00 | 0.00 | 0.00 | 0.00 | 56.56K |
Income Before Tax | -8.66M | -10.23M | -5.07M | -9.67M | -14.59M | -6.87M | -4.28M | -4.19M | -1.86M | -1.88M | -2.58M | 3.27K | -1.90B | -306.79M | 4.69B | 119.18K | -1.06M | -11.08M | 6.87M | -7.24M | -3.83M | -4.02M | -2.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -111.62% | -145.74% | -99.05% | -341.02% | -643.37% | -169.83% | -67.83% | -140.76% | -35.28% | -46.98% | -129.88% | 0.09% | -54,081.28% | -8,714.59% | 199,108.51% | 0.93% | -10.58% | -72.93% | 48.29% | -130.21% | -730.03% | -2,586.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -134.01K | 511.27K | -496.07K | 3.92M | 64.28K | 160.00 | 0.00 | 912.00 | 912.00 | 1.71K | 2.81K | 7.00 | 442.99K | -893.22K | -7.15M | -20.99K | -4.31M | 6.05M | -8.65M | 655.48K | 0.00 | 1.16M | -300.25K | 141.34K | 125.58K | 396.60K | -192.45K | 31.32K |
Net Income | -8.52M | -10.74M | -4.57M | -13.59M | -14.65M | -6.87M | -4.28M | -4.19M | -1.86M | -1.88M | -2.58M | 3.27K | -1.90M | -306.79K | 4.69M | 119.18K | -1.06M | -11.08M | 358.07K | -7.24M | -3.83M | -4.02M | -2.28M | -3.13M | -3.43M | -5.95M | -2.59M | -823.49K |
Net Income Ratio | -109.89% | -153.02% | -89.35% | -479.07% | -646.21% | -169.83% | -67.83% | -140.79% | -35.30% | -47.02% | -130.02% | 0.09% | -54.08% | -8.71% | 199.11% | 0.93% | -10.58% | -72.93% | 2.52% | -130.21% | -730.03% | -2,586.87% | 0.00% | -313,045,300.00% | -2,170.26% | -1,547.48% | -558.81% | -2,573.40% |
EPS | -15.21 | -23.87 | -10.56 | -52.04 | -148.35 | -4.73 | -5.15 | -6.00 | -2.70 | -3.06 | -5.40 | 0.01 | -4.66 | -0.76 | 11.52 | -9.60 | -3.46 | -42.35 | -17.28 | -39.92 | -41.87 | -58.35 | -40.12 | -62.68 | -79.23 | -152.46 | -71.04 | -16.04 |
EPS Diluted | -15.21 | -23.87 | -10.56 | -52.04 | -148.35 | -4.73 | -5.15 | -6.00 | -2.70 | -3.06 | -5.40 | 0.01 | -4.66 | -0.76 | 11.52 | -9.60 | -3.46 | -42.35 | -23.04 | -39.92 | -41.87 | -58.35 | -40.12 | -62.68 | -79.23 | -152.46 | -71.04 | -16.04 |
Weighted Avg Shares Out | 560.28K | 450.04K | 432.87K | 261.15K | 98.78K | 1.45M | 829.80K | 698.39K | 687.85K | 615.07K | 478.08K | 407.06K | 407.06K | 405.73K | 377.88K | 334.16K | 305.69K | 261.63K | 233.27K | 181.28K | 91.37K | 68.89K | 56.92K | 49.94K | 43.27K | 39.03K | 36.51K | 51.34K |
Weighted Avg Shares Out (Dil) | 560.28K | 450.04K | 432.87K | 261.15K | 98.78K | 1.45M | 829.80K | 698.39K | 687.85K | 615.07K | 478.08K | 407.06K | 407.06K | 405.73K | 377.88K | 334.16K | 305.69K | 261.63K | 271.07K | 181.28K | 91.37K | 68.89K | 56.92K | 49.94K | 43.27K | 39.03K | 36.51K | 51.34K |
Genesis HealthCare System Builds on its Investment in BIO-key Biometric Authentication Security as it Migrates to Epic Hyperdrive
BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers
BIO-key Showcasing Unique Identity, Authentication Innovations to Executives at Invite-Only Boston Cybersecurity Summit
BIO-key Awarded $800K Follow-On Order for Biometric User Authentication from Leading Government Defense Ministry
BIO-key International Announces Closing of $3.75 Million Public Offering
BIO-key International Announces Pricing of $3.75 Million Public Offering
Montenegro Ministry of Defense Selects BIO-key for Secure Data Access for All Ministry Employees With Multi-factor Authentication and Single Sign-On
Logistics Provider ALPI Portugal Selects BIO-key for Secure Data Access, Including Multi-factor Authentication and Single Sign-On, Both Internally and for B2B
Digital Authentication and Identity Provider BIO-key Sees Q3 Revenues Rising over 30% to $1.8M on Strength in Software License Fees, Services and Hardware Sales
Source: https://incomestatements.info
Category: Stock Reports